Nektar Therapeutics
NKTR
#8530
Rank
$0.15 B
Marketcap
$0.84
Share price
-2.71%
Change (1 day)
-5.92%
Change (1 year)

Operating Margin for Nektar Therapeutics (NKTR)

Operating Margin as of March 2025 (TTM): -121.10%

According to Nektar Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -121.10%. At the end of 2024 the company had an Operating Margin of -121.10%.

Operating Margin history for Nektar Therapeutics from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-121.10%-60.49%
2023-306.54%-22.69%
2022-396.48%-22.79%
2021-513.49%76.87%
2020-290.32%-24.38%
2019-383.93%-771.07%
201857.21%-283.24%
2017-31.22%-66.16%
2016-92.27%163.97%
2015-34.96%28.9%
2014-27.12%-74.72%
2013-107.28%-49.19%
2012-211.17%13.52%
2011-186.01%698.31%
2010-23.30%-83.69%
2009-142.88%266.66%
2008-38.97%238.26%
2007-11.52%-83.71%
2006-70.70%-51.8%
2005-146.70%64.27%
2004-89.31%104.01%
2003-43.77%-58.52%
2002-105.52%-26.16%
2001-142.90%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
13.78%-111.38%๐Ÿ‡บ๐Ÿ‡ธ USA
12.60%-110.40%๐Ÿ‡บ๐Ÿ‡ธ USA
31.06%-125.65%๐Ÿ‡บ๐Ÿ‡ธ USA
0.21%-100.17%๐Ÿ‡บ๐Ÿ‡ธ USA
16.07%-113.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
-4.61%-96.19%๐Ÿ‡บ๐Ÿ‡ธ USA
28.48%-123.52%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
18.78%-115.51%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.